Myopia, Progressive Clinical Trial
Official title:
A Double-blind, Randomized Controlled Study of Low Concentration Atropine in the Prevention of Myopia in Pre-myopia Children.
This double-blind, randomized controlled clinical study is to evaluate the effectiveness and safety of low concentration atropine in preventing myopia in pre-myopia children, and to explore whether there is a dose effect relationship between different concentrations of atropine in preventing myopia.
The main questions this double-blind, randomized controlled clinical study aims to answer are: 1. To evaluate the effect of low concentration atropine on the incidence of myopia in pre myopia children. 2. To evaluate the effectiveness of low concentration atropine in controlling refractive and axial progression. Patients are randomly divided into three treatment groups with different atropine concentrations(0.01%, 0.02%, 0.04%) and one control group with atropine dissolvant. Patients are required to use the eye drops every night for one year and record after daily usage. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05919654 -
Clinical Evaluation of MyoCare in Europe (CEME)
|
N/A | |
Recruiting |
NCT03402100 -
Eye Drops Study for Myopia Control in Schoolchildren
|
N/A | |
Recruiting |
NCT03865160 -
Low-dose Atropine for Myopia Control in Children
|
Phase 2/Phase 3 | |
Recruiting |
NCT06088225 -
Myopia Preventing With Distance-image Screen
|
N/A | |
Not yet recruiting |
NCT06085430 -
Kubota Glass Parameter Refinement Study
|
N/A | |
Not yet recruiting |
NCT06405711 -
To Evaluate the Efficacy and Safety of an Defocus Lens in Slowing the Progression of Myopia
|
N/A | |
Recruiting |
NCT05881655 -
Slow Myopia Progression With Different Irradiance Light
|
N/A | |
Recruiting |
NCT05761379 -
Clinical Study of Light Therapy to Control Myopia Progression in Children
|
N/A | |
Not yet recruiting |
NCT05760911 -
Myopia Prevention Through Monitoring and Motivating Outdoor Activities With Smartwatches
|
N/A | |
Recruiting |
NCT04722874 -
Repeated Low-Level Red-Light Therapy and Orthokeratology in Fast-progressing Myopia Control
|
N/A | |
Not yet recruiting |
NCT06221592 -
Differences and Wearing Safety and Comfort of New Defocus Incorporated Multiple Segments Spectacle Lenses
|
N/A | |
Completed |
NCT04806698 -
Long-term Efficacy of Orthokeratology Contact Lens Wear in Controlling the Progression of Childhood Myopia
|
N/A | |
Completed |
NCT04806763 -
Myopia Control With Orthokeratology Contact Lenses in Spain
|
N/A | |
Completed |
NCT04806711 -
Eleven Years of Menicon Z Night Contact Lens Wear in Reducing Myopia Progression in Children
|
N/A | |
Recruiting |
NCT05894382 -
Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control
|
N/A | |
Completed |
NCT05683535 -
Adverse Events Related to Low Dose Atropine
|
||
Completed |
NCT05300321 -
DIMS-myopia Progression ADN Axial Length Growth
|
N/A | |
Withdrawn |
NCT03519490 -
Can Distance Center and Near Center Multifocal Contact Lenses Control Myopia Progression in Children?
|
N/A | |
Completed |
NCT05372991 -
Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT05373693 -
Myopia-control Efficacy by Peripheral Defocus Lens (PDL)
|
N/A |